Home > Insider Trading > Filing (0001209191-13-039268)

Filing Details

Accession Number:: 0001209191-13-039268
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2013-08-05 17:35:57
Reporting Period:: 2013-08-02

Filing Date:: 2013-08-05
Accepted Time:: 2013-08-05 17:35:57
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1254419	Medassets Inc	MDAS	Services-Prepackaged Software (7372)	510391128

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1522395	A Gregory Strobel	100 North Point Center East Suite 200 Alpharetta GA 30022	President, Revenue Cycle Mgmt	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2013-08-02	4,025	$0.00	4,025	No	4	M	Direct
Common Stock	Disposition	2013-08-02	4,025	$22.78	0	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock-Settled Stock Appreciation Rights	Disposition	2013-08-02	9,000	$0.00	9,000	$15.57
Common Stock	Stock-Settled Stock Appreciation Rights	Disposition	2013-08-02	6,000	$0.00	6,000	$11.58

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
90,002		2018-03-03	No	4	M	Direct
76,002		2018-11-09	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership
Restricted Stock	7,914	Direct
Restricted Stock	11,871	Direct
Restricted Stock	11,871	Direct

Reported Derivative Holdings

Show Other Fields >>

Sec. Name	Sec. Type	Price	Date	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Stock	Stock Options (Right to Buy)	$22.45		2009-11-12	50,000	50,000	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2009-11-12	50,000	50,000	Direct

Footnotes

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.75 to $23.39, inclusive. The reporting person undertakes to provide to MedAssets, Inc., any security holder of MedAssets, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range noted.
The reporting person was granted these service-based restricted shares on February 25, 2013. The shares vest approximately 33.3% on each of March 1, 2014, 2015 and 2016.
The reporting person was granted these performance-based restricted shares on February 25, 2013. The shares vest approximately 33.3% on each of March 1, 2014, 2015 and 2016 based on the achievement of certain Company financial performance targets for fiscal year 2013.
The reporting person was granted these stock-settled stock appreciation rights (SSARs) on March 3, 2011. The SSARS vest equally (over the course of 60 months)beginning on March 1, 2011 such that 100% of the SSARs will be fully vested on February 1, 2016.
The reporting person was granted these SSARs on November 9, 2011. The SSARs vest equally (over the course of 60 months) beginning on November 1, 2011 such that 100% of the SSARs will be fully vested on October 1, 2016.
The reporting person was granted these stock options on November 12, 2009. The options vest equally (over the course of 60 months) on the first day of each month beginning on November 1, 2009, such that 100% of the options will be fully vested on October 1, 2014.